Vargatef®
nintedanib
About Vargatef®
Combination therapy with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally non-small cell lung cancer (NSCLC) of adenocarcinoma tumour histology after first-line chemotherapy.
Professional Area
You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.
Product Key Facts
Indications
Non-small cell lung cancer (NSCLC)
Brand Names
Vargatef®
Active ingredients
nintedanib